These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31403780)

  • 1. Design, Synthesis, and Biological Evaluation of Substituted 4,6-Dihydrospiro[[1,2,3]triazolo[4,5-
    Xu J; Xie X; Ye N; Zou J; Chen H; White MA; Shi PY; Zhou J
    J Med Chem; 2019 Sep; 62(17):7941-7960. PubMed ID: 31403780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of spiropyrazolopyridone derivatives as potent dengue virus inhibitors.
    Xu J; Xie X; Chen H; Zou J; Xue Y; Ye N; Shi PY; Zhou J
    Bioorg Med Chem Lett; 2020 Jun; 30(11):127162. PubMed ID: 32247736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Dengue Virus NS4B Inhibitors.
    Wang QY; Dong H; Zou B; Karuna R; Wan KF; Zou J; Susila A; Yip A; Shan C; Yeo KL; Xu H; Ding M; Chan WL; Gu F; Seah PG; Liu W; Lakshminarayana SB; Kang C; Lescar J; Blasco F; Smith PW; Shi PY
    J Virol; 2015 Aug; 89(16):8233-44. PubMed ID: 26018165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4B.
    Zhang X; Zhang N; Chen G; Turpoff A; Ren H; Takasugi J; Morrill C; Zhu J; Li C; Lennox W; Paget S; Liu Y; Almstead N; Njoroge FG; Gu Z; Komatsu T; Clausen V; Espiritu C; Graci J; Colacino J; Lahser F; Risher N; Weetall M; Nomeir A; Karp GM
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3947-53. PubMed ID: 23683597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [1,2,4]Triazolo[1,5-a]pyrimidine derivative (Mol-5) is a new NS5-RdRp inhibitor of DENV2 proliferation and DENV2-induced inflammation.
    Wan YH; Wu WY; Guo SX; He SJ; Tang XD; Wu XY; Nandakumar KS; Zou M; Li L; Chen XG; Liu SW; Yao XG
    Acta Pharmacol Sin; 2020 May; 41(5):706-718. PubMed ID: 31729469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Indole Derivatives as Novel and Potent Dengue Virus Inhibitors.
    Bardiot D; Koukni M; Smets W; Carlens G; McNaughton M; Kaptein S; Dallmeier K; Chaltin P; Neyts J; Marchand A
    J Med Chem; 2018 Sep; 61(18):8390-8401. PubMed ID: 30149709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus.
    Leal ES; Adler NS; Fernández GA; Gebhard LG; Battini L; Aucar MG; Videla M; Monge ME; Hernández de Los Ríos A; Acosta Dávila JA; Morell ML; Cordo SM; García CC; Gamarnik AV; Cavasotto CN; Bollini M
    Eur J Med Chem; 2019 Nov; 182():111628. PubMed ID: 31472473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates.
    Goethals O; Kaptein SJF; Kesteleyn B; Bonfanti JF; Van Wesenbeeck L; Bardiot D; Verschoor EJ; Verstrepen BE; Fagrouch Z; Putnak JR; Kiemel D; Ackaert O; Straetemans R; Lachau-Durand S; Geluykens P; Crabbe M; Thys K; Stoops B; Lenz O; Tambuyzer L; De Meyer S; Dallmeier K; McCracken MK; Gromowski GD; Rutvisuttinunt W; Jarman RG; Karasavvas N; Touret F; Querat G; de Lamballerie X; Chatel-Chaix L; Milligan GN; Beasley DWC; Bourne N; Barrett ADT; Marchand A; Jonckers THM; Raboisson P; Simmen K; Chaltin P; Bartenschlager R; Bogers WM; Neyts J; Van Loock M
    Nature; 2023 Mar; 615(7953):678-686. PubMed ID: 36922586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship study of the pyridine moiety of isothiazolo[4,3-b]pyridines as antiviral agents targeting cyclin G-associated kinase.
    Martinez-Gualda B; Pu SY; Froeyen M; Herdewijn P; Einav S; De Jonghe S
    Bioorg Med Chem; 2020 Jan; 28(1):115188. PubMed ID: 31757682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
    Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase.
    Xu HT; Colby-Germinario SP; Hassounah S; Quashie PK; Han Y; Oliveira M; Stranix BR; Wainberg MA
    Antimicrob Agents Chemother; 2016 Jan; 60(1):600-8. PubMed ID: 26574011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico designing and screening of lead compounds to NS5-methyltransferase of dengue viruses.
    Sivakumar D; Sivaraman T
    Med Chem; 2011 Nov; 7(6):655-62. PubMed ID: 22313305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.
    van Cleef KW; Overheul GJ; Thomassen MC; Kaptein SJ; Davidson AD; Jacobs M; Neyts J; van Kuppeveld FJ; van Rij RP
    Antiviral Res; 2013 Aug; 99(2):165-71. PubMed ID: 23735301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of covalent active site inhibitors of dengue virus protease.
    Koh-Stenta X; Joy J; Wang SF; Kwek PZ; Wee JL; Wan KF; Gayen S; Chen AS; Kang C; Lee MA; Poulsen A; Vasudevan SG; Hill J; Nacro K
    Drug Des Devel Ther; 2015; 9():6389-99. PubMed ID: 26677315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B protein.
    Tai VW; Garrido D; Price DJ; Maynard A; Pouliot JJ; Xiong Z; Seal JW; Creech KL; Kryn LH; Baughman TM; Peat AJ
    Bioorg Med Chem Lett; 2014 May; 24(10):2288-94. PubMed ID: 24731273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual targeting of dengue virus virions and NS1 protein with the heparan sulfate mimic PG545.
    Modhiran N; Gandhi NS; Wimmer N; Cheung S; Stacey K; Young PR; Ferro V; Watterson D
    Antiviral Res; 2019 Aug; 168():121-127. PubMed ID: 31085206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of N-alkylated deoxynojirimycin (DNJ) derivatives for the treatment of dengue virus infection.
    Yu W; Gill T; Wang L; Du Y; Ye H; Qu X; Guo JT; Cuconati A; Zhao K; Block TM; Xu X; Chang J
    J Med Chem; 2012 Jul; 55(13):6061-75. PubMed ID: 22712544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities.
    Pelliccia S; Wu YH; Coluccia A; La Regina G; Tseng CK; Famiglini V; Masci D; Hiscott J; Lee JC; Silvestri R
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1091-1101. PubMed ID: 28776445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 2-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,3,4-oxadiazole and 3-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,2,4-oxadiazole derivatives as dengue virus inhibitors targeting NS5 polymerase.
    Benmansour F; Eydoux C; Querat G; de Lamballerie X; Canard B; Alvarez K; Guillemot JC; Barral K
    Eur J Med Chem; 2016 Feb; 109():146-56. PubMed ID: 26774922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.
    Cregar-Hernandez L; Jiao GS; Johnson AT; Lehrer AT; Wong TA; Margosiak SA
    Antivir Chem Chemother; 2011 May; 21(5):209-17. PubMed ID: 21566267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.